Soros Fund Management’s Biohaven BHVN Stock Holding History

Soros Fund Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-202,903	Closed	-$2.82M	–	189
2022 Q4	$2.82M	Buy	+202,903	New	+$2.87M	0.04%	174

Other funds holding BHVN

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Soros Fund Management's BHVN Position: Q1 2023 in Review

Soros Fund Management sold out of Biohaven (BHVN) in Q1 2023, closing a stake of 202,903 shares — an estimated $2.82M sold.

Soros Fund Management first reported a position in BHVN in Q4 2022 and held it in 1 quarter. The position peaked at $2.82M in Q4 2022. 176 funds tracked by Wall St. Rank hold BHVN as of Q1 2023.

Soros Fund Management reported no remaining Biohaven position as of Q1 2023 after selling out during the quarter.
Soros Fund Management sold 202,903 Biohaven shares in Q1 2023, an estimated $2.82M.
Soros Fund Management first reported a position in Biohaven in Q4 2022 and held it in 1 quarter.
Soros Fund Management's Biohaven position peaked at $2.82M in Q4 2022.
176 funds tracked by Wall St. Rank held Biohaven as of Q1 2023.

Based on Soros Fund Management's 13F filing for Q1 2023, filed 12 May 2023.